FERMENTATION METHOD FOR PRODUCING A GIBBERELLIN

Abstract: Plant growth regulants including gibberellins are pro­ duced by fermentation of the phytopathogenic fungus Sphaceloma manihoticola, known to be the cause of the superelongation disease of cassava. In standard incubations, a wild type strain of S. manihoticola (DSM 1638) produces GA₄ in concentrations of up to about 7 mg per liter of culture filtrate. Other gibberellins, namely GA₉, GA₁₃, GA₁₄, GA₁₅, GA₂₄, GA₂₅, GA₃₆, and GA₃₇ are biosynthesized in smaller amounts. In contrast to Gibberella fujikuroi, the organism hitherto used to produce gibberellins commercially, no GA₁, GA₃ and GA₇ is synthesized by S. manihoticola. GA₄, as its main gibberellin can therefore be isolated in a pure form with simple means from culture filtrates of S. manihoticola.

Description: DESCRIPTION "MICROBIOLOGICAL PROCESS" This invention relates to a microbiological process and, more particularly, is concerned with a new process for the production of plant growth modifying compounds, preferably gibberellins, by fermentation. Gibberellins are a well recognised group of tetracyclic compounds which have great value as plant growth hormones. Many gibberellins are found to occur naturally in higher plants and other gibberellins have been produced microbiologically by fermentation. Over fifty naturally occurring gibberellins have been reported in the literature and biosynthesized gibberellins have also been subject to structural modification by chemical methods further increasing the number of known gibberellins. A gibberellin is regarded as a compound containing the tetracyclic ring system of ent-gibberellane shown below EMI1.1 Traditionally, gibberellins are biosynthesized by the fermentation of a species of the genus Gibberela. High yielding strains of the ascomycete Gibberella fuiikuroi have been developed and the fermentation of these high yielding strains provides the basis for commercial production of gibberellins. The fermentation of Gibberella fujikuroi results in the formation of a mixture of gibberellins containing predominantly GA3, GA4 and GA7. Methods have been developed for the separation of GA3 from the other fermentation products but, perhaps because of the structural similarities between GA4 and GA7, it is more difficult to separate these two gibberellins and consequently, the commercially available product normally contains a mixture of the two gibberellins in approximately equal amounts. Because of the potent plant growth modifying properties of the gibberellins, considerable research has been carried out since the 1950's to discover alternative microorganisms that might be used as a source of gibberellins with a view to identifying organisms that would provide still higher yields of gibberellins and/or be capable of more selective biosynthesis. Since the late 1950's, a large-number of microorganisms have been examined for this purpose but, prior to the present invention, there have been no reports that have been able to confirm conclusively the presence of gibberellins in the metabolites in any other microorganism other than one of the genus Gibberella. We have now been able to confirm the presence of significant quantities of gibberellins in the metabolites of a microorganism which is not a member of the genus Gibberella. Accordingly, the present invention provides a process for the production of a plant growth modifying compound, particular a gibberellin, which comprises fermenting a fungus which is a plant growth modifying compound producing species of the genus Sphaceloma and then isolating a plant growth modifying compound from the fermentation products. Our experimental work has concerned itself with the fermentation of the fungus responsible for the so called "super elongation" disease of the cassava crop in Colombia and which is believed to be identical with a species earlier named Sphaceloma manihoticola. The use of this particular microorganism in our invention is preferred. Earlier investigations into super elongation disease in cassava had not been able to identify the presence of gibberellins as being involved in the plant growth modification typical for infected plants. Sphaceloma manihoticola occurs naturally in Colombia and its morphological characteristics have been reported. We have found that two separate isolates of Sphaceloma manihoticola have been capable of producing exceptionally high yields of gibberellins and we have deposited the two strains in the Deutsche Sammlung von Mikroorganismen (DSM), Grisebachstrasse 8, 34 Gottingen, West Germany where they have been given the deposit numbers DSM No. 1637 and DSM No. 1638. We have surprisingly found that not only is Sphaceloma, a fungus morphologically distinct from the Gibberella, capable of producing high yields of gibberellins but also it is capable of producing a gibberellin which is substantially completely GA4. This is of considerable commercial importance since it is possible to isolate the GA4 from the culture by a simple solvent extraction step to give GA4 substantially free from other gibberellins. It is not necessary to carry out the expensive and time consuming separations that are necessary in the existing procedures involving the fermentation of Gibberella and, in particular, our invention enables GA4 to be produced biosynthetically free from GA7. Our fermentation is carried out under moderate fermentation conditions. We find that the fermentation temperature will normally be in the range of 15 to 300C, preferably 27-280C, and at a pH in the range 4 to 8, a pH of about 6.0 normally giving good results with our strains of Sphaceloma manihoticola on the substrates we have utilised. We have not found the substrate composition to be unduly critical and, subject to containing adequate sources of metabolisable carbon nitrogen and the normal trace elements, most natural or synthetic substrates are capable of supporting growth of the fungus. As a practical matter, we have been able to secure adequate growth of the fungus on a potato dextsPse medium and also on a synthetic medium based on glucose, ammonium nitrate, potassium dihydrogenphosphate and other inorganic salts to provide the necessary-trace elements. We have also found it is often advantageous to use disaccharides, especially maltose, rather than monosaccharides as the carbon source. We have found that the final yield of gibberellins produced in our fermentation process can be influenced significantly by the nitrogen-content of the substrate since it is the nitrogen content that determines the duration of mycelial growth during the fermentation and controls the onset of the secondary phase of growth during which the gibberellins and other metabolites are produced. The duration of the fermentation is governed by the criteria normally adopted in fermentation processes and, in order to maximise gibberellin yields, the fermentation should be continued for at least as long as gibberellins continue to be biosynthesized by the fungus. However, gibberellin production does fall away and no significant advantage is gained by prolonging the duration of the fermentation beyond this period. Once the fermentation is complete, the gibberellins may be recovered from the mycelial mass by solvent extraction. Any one of the organic solvents commonly used in the processing of gibberellins may be used and we have found that esters of simple alkane carboxylic acids are most convenient. Practical considerations point to the use of alkyl esters, for example, containing 1 to 4 carbon atoms in the alkyl group, of alkanoic acids containing 2 to 5 carbon atoms and we have found that the use of ethyl acetate is particularly convenient. Other organic solvents, for example, diethyl ether, may also be used for the extraction. The solvent extract containing the gibberellins may then be subjected to purification by methods conventionally used in gibberellin chemistry and thin layer chromatography has been found by us to effect a satisfactory degree of purification of the extract. We have used gas chromatography/mass spectrometry conclusively to identify GA4 as a metabolite produced by Sphaceloma and, we have measured the amounts of this gibberellin by the use of gas chromatography. These measurements have shown that Sphaceloma is capable, under appropriate fermentation conditions, of producing GA4 titres of of up to 7 mg/litre. The following Example is given to illustrate the invention. EXAMPLE Four different nutrient media are used: Medium 1 is a decoction of 300 g potatoes + 20 g glucose made up to a final volume of 1 1. Medium 1 was also diluted with water at the rate of 1 part of medium 1 by volume with 9 parts water by volume to form medium 2. Medium 3 is a synthetic medium of the following composition: 80 g glucose 0.48 g NiH4NO3 5,0 g KH2P04 1.0 g MgSO4. 2.0 ml iron stock solution* 2.0 ml micro element stock solution** final volume 1 1: pH 4.5 * 100 mg FeSO4:7H20 + ** 160 mg ZnSO4:7H20 134 mg Na2EDTA 15 mug CuSO4:7H20 solved in boiling water; 10 mg MnS04:7H20 final volume 100 ml 10 mg Na2Mo04:2H20 ad 100 ml Medium 4 is identical to medium 3, but the nitrogen content is increased by utilising 2.4 g NO . Medium 5 is identical to medium 3 but the glucose is replaced by maltose and an initial pH of 6.0. The micro-organisms used were Sphaceloma manihoticola No. 5 (DSM No. 1637) and No 43 (DSM No 1638) in the form of mycelial cultures 100 ml portions of the nutrient medium were introduced into a 500 ml flask and inoculated with the mycelial culture The inoculated medium was then incubated on a rotary shaker at 210C until fermentation was complete. This was found to take several days, and, for convenience, certain fermentations were permitted to continue for several weeks, although such prolonged fermentation periods are not believed to be essential The metabolites were then recovered from the fermentation medium after removal of mycelium by suction filtration or by centrifugation. The mycelial residue was washed with water to make the final aqueous extract 100 ml and the pH of the recovered liquid phase was adjusted to 2.7 with N-hydrochloric acid. The acidic solution was then extracted four times with 35 ml portions of ethyl acetate saturated with water. The combined ethyl acetate layers were extracted 3 times with 70 ml portions of 0.1 M K2HPO4 (saturated with ethyl acetate) which was then acidified to pH 2.7 with 5 N-hydrochloric acid, and extracted 4 times with 70 ml portions of ethylacetate saturated with water. The organic phases were combined and washed 4 times with 14 ml portions of water (whose pH was adjusted to 2.7 with hydrochloric acid). The organic phase was then concentrated under reduced pressure to remove the solvent and leave a residue of gibberellins. The solid gibberellin residue was purified by TLC on Merck Kieselgel 60 and developed with propanol-2: 25% ammonia:water (10:1:1, by volume). The pure gibberellins have Rf values: GA1=0.42, GA3=0.47, GA4=0.54, GA7=0.60, GAp=0.70. Different zones of the chromatogram were scraped off immediately after development, homogenised in a mortar, and eluted with methanol in Pasteur pipettes. The gibberellin activity was measured with the lettuce hypocotyl bioassay (Nature 185, 255-256). We found gibberellin activity only in the fraction having Rf from 0.5 to 0.6 indicating that our gibberellin product could be GA4 or GA7, and that no significant quantities of GA3 or GA1 were present. The extracted materials were also subjected, after methylation and trimethylsilation, to gas chromatography analysis and again, a single main component was identified having a retention time identical to that of GA4 but different from that of GA7. The identity of this material as GA4 was confirmed by gas chromatography/mass spectrometry using a methylated and trimethylsilylated sample of the extracted material. The gas chromatography and gas chromatography/mass spectrometry techniques failed to reveal any other gibberellins recovered from the Mycelial mass confirming the GA4 selectivity of strains of Sphaceloma manihoticola used in our experiments. The GA4 titres obtained on our fermentations are set out in the following Table: TABLE EMI8.1 <tb> Organism <SEP> Medium <SEP> Duration <SEP> pH <SEP> of <SEP> GA4 <tb> Sphaceloma <SEP> of <SEP> fer- <SEP> medium <SEP> content <tb> manihoticola <SEP> mentation <SEP> after <SEP> (ug/l) <SEP> <tb> <SEP> (days) <SEP> incub. <SEP> <tb> DSM <SEP> 1637 <SEP> 1 <SEP> 3 <SEP> n.d. <SEP> <tb> DSM <SEP> 1638 <SEP> 1 <SEP> 3 <SEP> n.d. <SEP> <tb> DSM <SEP> 1637 <SEP> 1 <SEP> 14 <SEP> n.d. <SEP> 90 <tb> DSM <SEP> 1638 <SEP> 2 <SEP> 11 <SEP> 7.3 <SEP> 400 <tb> DSM <SEP> 1637 <SEP> 3 <SEP> - <SEP> 64 <SEP> 4.9 <SEP> - <SEP> - <SEP> 320 <tb> DSM <SEP> 1638 <SEP> 3 <SEP> 64 <SEP> 4.0 <SEP> - <SEP> 10 <tb> DSM <SEP> 1638 <SEP> - <SEP> 4 <SEP> 76 <SEP> 6.0 <SEP> 2920 <SEP> <tb> DSM <SEP> 1638 <SEP> 3/Ca++ <SEP> 61 <SEP> 4.0 <SEP> - <SEP> 30 <tb> DSM <SEP> 1638 <SEP> ' <SEP> 5 <SEP> (temper- <SEP> 25 <SEP> - <SEP> 5.4 <SEP> 7320 <tb> <SEP> ature <SEP> of <tb> <SEP> ferment <tb> <SEP> ation <SEP> is <tb> <SEP> 27 C) <SEP> <tb> Combined gas chromatography/mass spectrometry shows that in addition to GA4, strains DSM 1637 and 1638 are capable of producing the following further gibberellins, the percentages indicated being percentages by weight of GA4 produced in the fermentation. GA13 (25%), GA14 (5%) GA24 (0.5%) GAg (0.2%) and traces of GA15, GA25, GA36 and GA37. The extremely sensitive mass gragmentation technique revealed no traces of GA1, GA3 or GA7 in the fermentation products

Claims: CLAIMS 1. A method of producing a plant growth modifying compound by fermenting a plant growth modifying compound producing species of the genus Sphaceloma and isolating a plant growth modifying compound from the fermentation product. 2. A method according to claim 1 wherein the plant growth modifying compound is a gibberellin. 3. A method according to claim 1 or 2 wherein the species is Sphaceloma manihoticola. 4. A method according to claim 3 wherein the species is Sphaceloma manihoticola DSM 1637 or DSM 1638. 5. A method according to any one of the preceding claims wherein the fermentation is carried out at 27-280C at an initial pH of about 6. 6. A method according to any one of the preceding claims wherein the fermentation is carried out in the presence of maltose as carbon source. 7. A method according to any one of the preceding claims wherein the plant growth modifying compound produced by fermentation is predominantly GA4 and is substantially free from GA7.

Inventors: GRAEBBE, JAN EILER, RADEMACHER, WILHELM
Applicants: NORSK HYDRO A/S
Application year: 1980
Main classification: C12P27
IPC codes: C12P27